Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated the efficacy and safety of Brivaracetam in participants with epilepsy, including partial-onset seizures with or without secondary g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Briviact (brivaracetam)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Partial Seizures With or Without Secondary Generalization, Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2023-11-09